Bastadin 6, a spongean brominated tyrosine derivative, inhibits tumor angiogenesis by inducing selective apoptosis to endothelial cells
暂无分享,去创建一个
M. Shibuya | S. Nakagawa | T. Mayumi | M. Kuwano | M. Ono | S. Aoki | Motomasa Kobayashi | Jianqing Gao | S. Nakao | T. Kuwano | S. Cho | Motomasa Kobayashi
[1] Yukihiro Asami,et al. RK-805, an endothelial-cell-growth inhibitor produced by Neosartorya sp., and a docking model with methionine aminopeptidase-2 , 2004 .
[2] P. O'dwyer,et al. Monoclonal antibodies in the treatment of colorectal cancer. , 2004, European journal of cancer.
[3] S. Kihara,et al. Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[4] Ricky T. Tong,et al. Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer , 2004, Nature Medicine.
[5] E. Anaissie,et al. Phase II Study of SU5416, a Small Molecule Vascular Endothelial Growth Factor Tyrosine Kinase Receptor Inhibitor, in Patients with Refractory Multiple Myeloma , 2004, Clinical Cancer Research.
[6] Philip Hahnfeldt,et al. Combined therapy with direct and indirect angiogenesis inhibition results in enhanced antiangiogenic and antitumor effects. , 2003, Cancer research.
[7] F. Rastinejad,et al. Pharmacological characterization of CP-547,632, a novel vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for cancer therapy. , 2003, Cancer research.
[8] R. Gilbert,et al. STI-571 inhibits in vitro angiogenesis. , 2003, Biochemical and biophysical research communications.
[9] J. Mier,et al. Canstatin Inhibits Akt Activation and Induces Fas-dependent Apoptosis in Endothelial Cells* , 2003, Journal of Biological Chemistry.
[10] N. Chandel,et al. Angiostatin4.5-mediated Apoptosis of Vascular Endothelial Cells , 2003 .
[11] N. Chandel,et al. Angiostatin(4.5)-mediated apoptosis of vascular endothelial cells. , 2003, Cancer research.
[12] B. Curry,et al. ZD6474 inhibits vascular endothelial growth factor signaling, angiogenesis, and tumor growth following oral administration. , 2002, Cancer research.
[13] He-long Zhang,et al. Activity of a new vascular targeting agent, ZD6126, in pulmonary metastases by human lung adenocarcinoma in nude mice. , 2002, Cancer research.
[14] T. Furukawa,et al. Lembehsterols A and B, novel sulfated sterols inhibiting thymidine phosphorylase, from the marine sponge Petrosia strongylata. , 2002, Chemical & pharmaceutical bulletin.
[15] M. Kuwano,et al. ZD1839 (Iressa) induces antiangiogenic effects through inhibition of epidermal growth factor receptor tyrosine kinase. , 2002, Cancer research.
[16] K. Weinberg,et al. αv‐Integrin antagonist EMD 121974 induces apoptosis in brain tumor cells growing on vitronectin and tenascin , 2002, International journal of cancer.
[17] D. Gingras,et al. The antiangiogenic agent neovastat (AE-941) inhibits vascular endothelial growth factor-mediated biological effects. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[18] J. Fargnoli,et al. Inhibition of angiogenesis and metastasis in two murine models by the matrix metalloproteinase inhibitor, BMS-275291. , 2001, Cancer research.
[19] A. Pries,et al. Expression of ryanodine receptor type 3 and TRP channels in endothelial cells: comparison of in situ and cultured human endothelial cells. , 2001, Cardiovascular research.
[20] T. L. Moser,et al. Endothelial cell surface F1-FO ATP synthase is active in ATP synthesis and is inhibited by angiostatin , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[21] M. Hitt,et al. Combined Treatment of a Murine Breast Cancer Model with Type 5 Adenovirus Vectors Expressing Murine Angiostatin and IL-12: A Role for Combined Anti-Angiogenesis and Immunotherapy1 , 2001, The Journal of Immunology.
[22] S. Pizzo,et al. 内皮細胞表面F1‐F0ATPシンターゼはATP合成に働き、アンギオスタチンにより阻害される , 2001 .
[23] Cherrington,et al. SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors. , 2000, Cancer research.
[24] Eric C. Griffith,et al. Cell cycle inhibition by the anti-angiogenic agent TNP-470 is mediated by p53 and p21WAF1/CIP1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[25] R. Kalluri,et al. Canstatin, a Novel Matrix-derived Inhibitor of Angiogenesis and Tumor Growth* , 2000, The Journal of Biological Chemistry.
[26] O. Volpert,et al. Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1 , 2000, Nature Medicine.
[27] T. Molinski,et al. Bastadin 10 Stabilizes the Open Conformation of the Ryanodine-sensitive Ca2+ Channel in an FKBP12-dependent Manner* , 1999, The Journal of Biological Chemistry.
[28] V. Sukhatme,et al. Endostatin Induces Endothelial Cell Apoptosis* , 1999, The Journal of Biological Chemistry.
[29] A. Ullrich,et al. SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types. , 1999, Cancer research.
[30] Eric C. Griffith,et al. Molecular recognition of angiogenesis inhibitors fumagillin and ovalicin by methionine aminopeptidase 2. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[31] Leonard,et al. Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders. , 1997, Cancer research.
[32] M. Shibuya,et al. The 230 kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLC-γ pathway and partially induces mitotic signals in NIH3T3 fibroblasts , 1997, Oncogene.
[33] H. Krutzsch,et al. Thrombospondin 1 and type I repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells. , 1997, Cancer research.
[34] T. Molinski,et al. Bastadins relate ryanodine-sensitive and -insensitive Ca2+ efflux pathways in skeletal SR and BC3H1 cells. , 1997, The American journal of physiology.
[35] M. Shibuya,et al. A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF. , 1995, Oncogene.
[36] T. Molinski,et al. Novel modulators of skeletal muscle FKBP12/calcium channel complex from Ianthella basta. Role of FKBP12 in channel gating. , 1994, The Journal of biological chemistry.
[37] D. Ingber,et al. Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470). , 1994, British Journal of Cancer.
[38] M. Mack,et al. Novel Modulators of Skeletal Muscle FKBPWCalcium Channel Complex from Ianthella basta , 1994 .
[39] A. Yoshimura,et al. Angiogenic factor , 1992, Nature.
[40] J. Blount,et al. Brominated tyrosine-derived metabolites from the sponge Ianthella basta , 1980 .